Robert Torray - Torray Investment Partners
Holding/activity history for Myovant Sciences (MYOV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q4 | 0 | 0.00 | Sell 100.00% | 0.28 | SEC | ||
| 2022 Q3 | 79,171 | 0.28 | Reduce 3.00% | <0.01 | $17.96 | $1,422,000 | SEC |
| 2022 Q2 | 81,621 | 0.19 | Add 2.19% | <0.01 | $12.44 | $1,015,000 | SEC |
| 2022 Q1 | 79,868 | 0.17 | Add 45.27% | 0.05 | $13.32 | $1,064,000 | SEC |
| 2021 Q4 | 54,979 | 0.13 | Reduce 26.01% | 0.07 | $15.57 | $856,000 | SEC |
| 2021 Q3 | 74,305 | 0.26 | Add 0.82% | <0.01 | $22.43 | $1,667,000 | SEC |
| 2021 Q2 | 73,704 | 0.25 | Add 16.54% | 0.04 | $22.77 | $1,678,000 | SEC |
| 2021 Q1 | 63,241 | 0.20 | Add 2.19% | <0.01 | $20.57 | $1,301,000 | SEC |
| 2020 Q4 | 61,885 | 0.28 | Add 1.02% | <0.01 | $27.62 | $1,709,000 | SEC |
| 2020 Q3 | 61,262 | 0.16 | Add 17.71% | 0.02 | $14.05 | $861,000 | SEC |
| 2020 Q2 | 52,044 | 0.20 | Buy | 0.20 | $20.62 | $1,073,000 | SEC |